520
Participants
Start Date
February 28, 2011
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
fexofenadine HCL (M016455)
Pharmaceutical form:tablet Route of administration: oral
pseudoephedrine
"Pharmaceutical form:tablet~Route of administration: oral"
fexofenadine HCL matching placebo
"Pharmaceutical form:tablet~Route of administration: oral"
pseudoephedrine matching placebo
"Pharmaceutical form:tablet~Route of administration: oral"
Investigational Site Number 392002, Koganeishi
Investigational Site Number 392003, Osaka
Investigational Site Number 392001, Shinjuku-Ku
Lead Sponsor
Sanofi
INDUSTRY